Educational information, not medical advice — ask your doctor or midwife.
Bifidobacterium longum is one of the most studied and prevalent beneficial bacteria in the human gut. It naturally colonizes the intestines from birth — especially in breastfed infants — and remains an important resident throughout adult life. It belongs to the Bifidobacterium genus, a group of bacteria central to gut health across virtually every human population on earth.
B. longum works by fermenting dietary fibers into short-chain fatty acids like butyrate, which nourish the gut lining and reduce inflammation. It also competes with harmful bacteria for space and nutrients, produces natural antimicrobial compounds, and communicates with the immune system to help calibrate its responses. Emerging research shows it also influences the gut-brain axis, affecting mood-related neurotransmitter pathways.
Supplements come as capsules, powders, or sachets — often paired with other probiotic strains or prebiotics (synbiotics). Enteric-coated capsules help the bacteria survive stomach acid. It also occurs naturally in fermented dairy like yogurt and kefir, though supplement doses are generally much higher than what food provides.
Bifidobacterium was first identified by French pediatrician Henry Tissier in 1900 in the stool of breastfed infants. He noted its dominance in healthy infant guts and proposed its protective role against diarrheal disease — an observation that has held up remarkably well over 120 years of research. It remains one of the foundational probiotic strains in both clinical and consumer settings globally.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.